DOROTHY STARLING: Open Payments
NPI 1285919399 · TROY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,300 in 68 payments from 17 companies in 2025. Trend: 2023 $1,750 · 2024 $1,556 · 2025 $1,300
Food & beverage: $1,100Education: $200
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $300 |
| ABBVIE INC. | 24 | $290 |
| Lilly USA, LLC | 8 | $142 |
| UCB, Inc. | 6 | $136 |
| Amgen Inc. | 3 | $83 |
| GENZYME CORPORATION | 3 | $55 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $40 |
| Novartis Pharmaceuticals Corporation | 2 | $40 |
| Galderma Laboratories, L.P. | 2 | $34 |
| Organogenesis Inc. | 1 | $29 |
Products named: TREMFYA, SKYRIZI, EBGLYSS, Bimzelx, RINVOQ, OTEZLA, DUPIXENT, ILUMYA.
Industry payments across NY — which companies pay providers there.
